You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0195 Preferential Inhibition of IL-6 Relative To IL-7 Signaling Pathways by ABT-494: Exposure-Response Analysis of ex-Vivo Data from Two Phase 1 Clinical Trials and Comparison To Tofacitinib

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - non-biologic treatment and small molecules
THU0195 Preferential Inhibition of IL-6 Relative To IL-7 Signaling Pathways by ABT-494: Exposure-Response Analysis of ex-Vivo Data from Two Phase 1 Clinical Trials and Comparison To Tofacitinib

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mohamed M, Koenig D, Camp H, et al
THU0195 Preferential Inhibition of IL-6 Relative To IL-7 Signaling Pathways by ABT-494: Exposure-Response Analysis of ex-Vivo Data from Two Phase 1 Clinical Trials and Comparison To Tofacitinib
Annals of the Rheumatic Diseases 2016;75:256.